Clover Health Files 8-K: Other Events Reported
Ticker: CLOV · Form: 8-K · Filed: Oct 25, 2024 · CIK: 1801170
| Field | Detail |
|---|---|
| Company | Clover Health Investments, Corp. /De (CLOV) |
| Form Type | 8-K |
| Filed Date | Oct 25, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001, $250,000 |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, regulatory-filing, other-events
Related Tickers: CLOV
TL;DR
CLOV filed an 8-K for 'Other Events' on 10/23. Details TBD.
AI Summary
Clover Health Investments Corp. filed an 8-K on October 25, 2024, reporting an event on October 23, 2024. The filing is under 'Other Events' and does not specify the nature of the event in the provided text, but it confirms the company's legal name, incorporation in Delaware, and principal executive offices in Franklin, Tennessee.
Why It Matters
This filing indicates a material event has occurred for Clover Health, requiring public disclosure. Investors should look for subsequent filings or press releases to understand the specific nature and impact of this event.
Risk Assessment
Risk Level: medium — An 8-K filing under 'Other Events' suggests a significant development that could impact the company's stock, but the lack of specific details in this excerpt necessitates caution.
Key Numbers
- 001-39252 — SEC File Number (Identifies the company's filing with the SEC.)
- 98-1515192 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- CLOVER HEALTH INVESTMENTS, CORP. (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- Franklin, Tennessee (location) — Principal Executive Offices
- October 23, 2024 (date) — Date of earliest event reported
- October 25, 2024 (date) — Filing Date
FAQ
What specific event is reported under 'Other Events' in this 8-K filing?
The provided text of the 8-K filing does not specify the nature of the 'Other Events' reported on October 23, 2024.
When was this 8-K filing submitted to the SEC?
The 8-K filing was submitted to the SEC on October 25, 2024.
Where are Clover Health Investments Corp.'s principal executive offices located?
Clover Health Investments Corp.'s principal executive offices are located at 3401 Mallory Lane, Suite 210, Franklin, Tennessee 37067.
In which state is Clover Health Investments Corp. incorporated?
Clover Health Investments Corp. is incorporated in Delaware.
What is the SEC file number for Clover Health Investments Corp.?
The SEC file number for Clover Health Investments Corp. is 001-39252.
Filing Stats: 520 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-10-25 16:05:53
Key Financial Figures
- $0.0001 — stered Class A Common Stock, par value $0.0001 per share CLOV The NASDAQ Stock Market
- $250,000 — hange for a payment by Clover Health of $250,000 to Plaintiff's counsel. SIGNATURE P
Filing Documents
- clov-20241023.htm (8-K) — 24KB
- 0001801170-24-000220.txt ( ) — 148KB
- clov-20241023.xsd (EX-101.SCH) — 2KB
- clov-20241023_lab.xml (EX-101.LAB) — 22KB
- clov-20241023_pre.xml (EX-101.PRE) — 13KB
- clov-20241023_htm.xml (XML) — 3KB
01. Other Events
Item 8.01. Other Events. As previously disclosed, on March 26, 2024, Plaintiff Bruce Taylor ("Plaintiff"), a putative shareholder of Clover Health Investments, Corp. (the "Company"), filed a putative class action complaint, captioned Bruce Taylor v. Chelsea Clinton, et al., C.A. No. 2024-0305-MTZ (Del. Ch.) (the "Action"), against the Company and its directors in the Delaware Court of Chancery challenging a Company bylaw governing the process for nominating a candidate to the Company's board of directors as preclusive and coercive. Also as previously disclosed, in June 2024, the Company adopted an amendment to its bylaws mooting the Action, and the Plaintiff voluntarily dismissed the suit, with the court retaining jurisdiction solely for the purpose of determining Plaintiff's counsel's application for attorneys' fees and reimbursement of expenses (the "Fee Application"). Solely to avoid the time and expense of continued litigation, the parties agreed to resolve the Fee Application in exchange for a payment by Clover Health of $250,000 to Plaintiff's counsel. SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Clover Health Investments, Corp. Date: October 25, 2024 By: /s/Karen M. Soares Name: Karen M. Soares Title: General Counsel and Corporate Secretary